Remove Assay Development Remove Compound Screening Remove Drugs
article thumbnail

Sygnature Discovery completes acquisition of SB Drug Discovery to further strengthen its market-leading capabilities

Sygnature Discovery

Sygnature Discovery (“Sygnature”) is delighted to announce the acquisition of SB Drug Discovery, a world leading provider of ion channel and receptor drug discovery research delivering cell line generation and compound screening solutions in neuroscience and other therapeutic indications.

article thumbnail

Target-directed cancer: protein-ligand interactions  

Drug Target Review

Could you provide an overview of your research on target directed cancer drug discovery, particularly your focus on protein lagging interactions. I work in the Centre for Cancer Drug Discovery (CCDD) at The Institute of Cancer Research in London, which is an academic drug discovery centre. 2013) 56, 2059-2073.

article thumbnail

A trusted partner in drug discovery: Viral Patel’s 20-year journey with mosquito®

sptlabtech

Since 2003, mosquito has been a trusted solution in drug discovery, used by hundreds of pharmaceutical, biotech, and academic labs worldwide. These capabilities make it an invaluable tool for applications ranging from compound screening and medicinal chemistry to molecular and structural biology.

Drugs 59